Clinical Trials in Portland

Showing 8561-8580 of 10,048 trials

Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT00182689

This phase II trial is studying how well sorafenib works in treating patients with extensive stage small cell lung cancer. Sorafenib may stop the growth of small cell lung cancer by blocking blood flow to the tumor and by blocking some of the enzymes needed for cell growth.

Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer

National Cancer Institute (NCI)89 participantsStarted Jul 2005

Portland, Oregon, United States

COMPLETEDPhase 4< 1 mile

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

NCT00153101

The Ongoing Telmisartan Alone and in combination wiht Ramipril Global Endpoint trial (ONTARGET): The primary objectives are to determine if (a) telmisartan 80mg daily and ramipril 10mg daily combination therapy is more effective in reducing the composite endpoint of Cardiovascular Death (CV) death, Myocardial infarction (MI), stroke or hospitalization for Congestive Heart Failure (CHF) compared with ramipril 10mg alone; and (b) telmisartan 80mg daily is at least as effective as (i.e. not less effective than) ramipril 10mg daily, on this endpoint. Telmisartan Randomised Assessment Study in Angiotension converting Enzyme inhibitor intolerant subjects with Cardiovascular Disease. (TRANSCEND): The primary objective of the study is to determine if treatment with telmisartan 80mg daily is superior to placebo reducing the composite endpoint of Cardiovascular Death (CV), Myocardial Infarction ( MI)I, stroke or hospitalization for Congestive Heart Failure (CHF) in patients who are intolerant to Angiotension Converting Enzyme inhibitors.

Cardiovascular Diseases

Boehringer Ingelheim31,546 participantsStarted Nov 2001

Athens, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +729 more locations

Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Find Trials by Condition in Portland

Collection of Blood Samples From HIV Infected People

S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas

Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

Tiotropium / Respimat One Year Study in COPD.

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Study of Epratuzumab in Systemic Lupus Erythematosus

Secondary Prevention of Venous Thrombo Embolism (VTE).

Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

National Lung Screening Trial (NLST) Screening